UC San Diego Health News

UC San Diego Health, the region’s only academic medical center, delivers world-class care and translates groundbreaking research into promising new treatments for patients.

UC San Diego Health Website

The Latest

Pressing Reset on Depression (external site)

Transcranial magnetic stimulation offers hope for antidepressant-resistant psychiatric disorders at UC San Diego Health.

Presence of Staph Bacteria in Skin Microbiome Promotes Netherton Syndrome Inflammation (external site)

Netherton syndrome is exacerbated by the presence of Staphylococcus aureus and Staphylococcus epidermidis living on human skin report University of California San Diego School of Medicine researchers.

Predicting Autism Risk May Begin With a Drop of Blood (external site)

A novel research study by UC San Diego researchers will determine whether testing stored blood drops, recorded at birth, for 1,000 different molecules and chemicals can help predict autism risk years before symptoms would likely appear.

Preclinical Data Shows Combination Immunotherapy Could Stop Liver Cancer Growth (external site)

New preclinical data from University of California San Diego School of Medicine and Moores Cancer Center offers proof-of-principle for a combination immunotherapy that suppresses tumor growth in the liver. Current therapies for liver cancer are largely ineffective, resulting in poor outcomes.

Potential Drug Target for Difficult-To-Treat Breast Cancer: RNA-Binding Proteins (external site)

UC San Diego studies using human cell lines and tumors grown in mice provide early evidence that inhibiting RNA-binding proteins, a previously overlooked family of molecules, might provide a new approach for treating some cancers.

Precision Medicine Identifies Key Recurring Mutation in Head and Neck Cancers (external site)

Researchers at UC San Diego School of Medicine and Moores Cancer Center report that an investigational drug candidate called tipifarnib showed promise in treating key recurring mutation in head and neck cancers.